Does RISANKIZUMAB-RZAA Cause Extra dose administered? 10 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Extra dose administered have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
10
Reports of Extra dose administered with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
1
Hospitalizations
How Dangerous Is Extra dose administered From RISANKIZUMAB-RZAA?
Of the 10 reports, 1 (10.0%) required hospitalization.
Is Extra dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Extra dose administered?
TIRZEPATIDE (6,774)
DULAGLUTIDE (3,047)
LORATADINE (1,556)
DUPILUMAB (1,422)
FEXOFENADINE (1,413)
NAPROXEN (908)
POLYETHYLENE GLYCOL 3350 (589)
ACETAMINOPHEN (552)
DALFAMPRIDINE (519)
FLUTICASONE\SALMETEROL (499)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Extra dose administered Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA